Last update 21 Nov 2024

ABO2011

Overview

Basic Info

Drug Type
mRNA
Synonyms
Target
IL-12
Mechanism
IL-12 stimulants(Interleukin-12 stimulants)
Therapeutic Areas
Neoplasms
Active Indication
Advanced Malignant Solid Neoplasm
Inactive Indication-
Originator Organization
Suzhou Abogen Biosciences Co., Ltd.Suzhou Abogen Biosciences Co., Ltd.
Active Organization
Suzhou Abogen Biosciences Co., Ltd.Suzhou Abogen Biosciences Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with ABO2011
CTR20232745 / RecruitingPhase 1
一项在系统性标准治疗后进展或转移的晚期实体瘤患者中评估ABO2011单药安全性、药代动力学和药效学（PK/PD）及初步有效性的I期临床研究
[Translation] A Phase I clinical study to evaluate the safety, pharmacokinetics and pharmacodynamics (PK/PD) and preliminary efficacy of ABO2011 monotherapy in patients with advanced solid tumors that have progressed or metastasized after systemic standard treatment
NCT06088004 / RecruitingPhase 1/2
A Phase I/II Clinical Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics (PK/PD) and Preliminary Efficacy of ABO2011 Monotherapy or in Combination with Toripalimab in Patients with Advanced Solid Tumors
CTR20240149 / RecruitingPhase 1/2
一项在晚期实体瘤患者中评估ABO2011单药及与特瑞普利单抗联合的安全性、药代动力学和药效学（PK/PD）及初步有效性的I/II期临床研究
[Translation] A Phase I/II clinical study evaluating the safety, pharmacokinetics and pharmacodynamics (PK/PD) and preliminary efficacy of ABO2011 alone and in combination with toripalimab in patients with advanced solid tumors
100 Clinical Results associated with ABO2011
Login to view more data
100 Translational Medicine associated with ABO2011
Login to view more data
100 Patents (Medical) associated with ABO2011
Login to view more data
100 Deals associated with ABO2011
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 2
CN
Suzhou Abogen Biosciences Co., Ltd.Suzhou Abogen Biosciences Co., Ltd.
28 Sep 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free